Response to "DPYD genotyping panels: Impact of population diversity".

Gaedigk, Andrea; Turner, Amy J; Haidar, Cyrine E; Empey, Philip E; Offer, Steven M

Gaedigk, Andrea; Turner, Amy J; Haidar, Cyrine E; Empey, Philip E; Offer, Steven M.

Afiliação

Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute (CMRI), Kansas City, Missouri, USA.
Turner AJ; RPRD Diagnostics LLC, Milwaukee, Wisconsin, USA.
Haidar CE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Empey PE; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
Offer SM; Department of Pathology, University of Iowa, Iowa City, Iowa, USA.

Clin Transl Sci ; 17(4): e13806, 2024 Apr.

Article em En | MEDLINE | ID: mdl-38637962

Assuntos

Fluoruracila; Humanos; Genótipo; Capecitabina

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluoruracila Limite: Humans Idioma: En Revista: Clin Transl Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google